Thomas L. Gallagher
Molecular Biology · 2024
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 29 citations into it
- Genetics — 23 citations into it
- Cardiology and Cardiovascular Medicine — 7 citations into it
Whom Thomas L. Gallagher trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Thomas L. Gallagher's perspective
Ordered by how strongly the researchers Thomas L. Gallagher trusts endorse each paper. Same corpus, a different order for every researcher.
- AAV5–Factor VIII Gene Transfer in Severe Hemophilia A (New England Journal of Medicine)
- Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy (Proceedings of the National Academy of Sciences of the United States of America)
- Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues (Journal of Virology)
- Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector (Nature Genetics)
- Complement System Part I – Molecular Mechanisms of Activation and Regulation (Frontiers in Immunology)
- Deep diversification of an AAV capsid protein by machine learning
- Worldwide Epidemiology of Neutralizing Antibodies to Adeno-Associated Viruses (Journal of Infectious Diseases)
- Duchenne muscular dystrophy (Nature Reviews Disease Primers)
- Regulation of Immune Responses by mTOR (Annual Review of Immunology)
- Gene therapy comes of age (Science)
Their papers
- Adeno-associated virus as a delivery vector for gene therapy of human diseases (2024) — 705 citations